Bharat Biotech partner Ocugen to set up RnD centre in Hyderabad
Advertisement
Hyderabad: Ocugen, a USA-based biotechnology company is planning to establish a research and development (R&D) centre in Telangana that will focus on developing cutting-edge modifier gene therapies and regenerative cell therapy targeting unmet medical needs, and vaccines to support public health. An official release said the centre will make a positive economic impact in the region and provide a significant number of jobs over the next few years.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.